Notice2026-06741
Fatty Acids From Indonesia and Malaysia; Determinations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 8, 2026
Issuing agencies
International Trade Commission
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 67 (Wednesday, April 8, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 67 (Wednesday, April 8, 2026)]
[Notices]
[Page 17814]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-06741]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-785-786 and 731-TA-1773-1774 (Preliminary)]
Fatty Acids From Indonesia and Malaysia; Determinations
On the basis of the record \1\ developed in the subject
investigations, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that there is a reasonable indication that an industry in the
United States is materially injured by reason of imports of fatty acids
from Indonesia and Malaysia, provided for in subheadings 2915.70.01,
2915.90.10, 2916.15.10, 2916.15.51, 3823.11.00, 3823.12.00, 3823.19.20,
and 3823.19.40 of the Harmonized Tariff Schedule of the United States,
that are alleged to be sold in the United States at less than fair
value (``LTFV'') and imports of the subject merchandise from Indonesia
and Malaysia that are alleged to be subsidized by the governments of
Indonesia and Malaysia.\2\
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
\2\ 91 FR 12342 and 91 FR 12353 (March 13, 2026).
---------------------------------------------------------------------------
Commencement of Final Phase Investigations
Pursuant to section 207.18 of the Commission's rules, the
Commission also gives notice of the commencement of the final phase of
its investigations. The Commission will issue a final phase notice of
scheduling, which will be published in the Federal Register as provided
in Sec. 207.21 of the Commission's rules, upon notice from the U.S.
Department of Commerce (``Commerce'') of affirmative preliminary
determinations in the investigations under Sec. Sec. 703(b) or 733(b)
of the Act, or, if the preliminary determinations are negative, upon
notice of affirmative final determinations in those investigations
under Sec. Sec. 705(a) or 735(a) of the Act. Parties that filed
entries of appearance in the preliminary phase of the investigations
need not enter a separate appearance for the final phase of the
investigations. Any other party may file an entry of appearance for the
final phase of the investigations after publication of the final phase
notice of scheduling. Industrial users, and, if the merchandise under
investigation is sold at the retail level, representative consumer
organizations have the right to appear as parties in Commission
antidumping and countervailing duty investigations. The Secretary will
prepare a public service list containing the names and addresses of all
persons, or their representatives, who are parties to the
investigations. As provided in section 207.20 of the Commission's
rules, the Director of the Office of Investigations will circulate
draft questionnaires for the final phase of the investigations to
parties to the investigations, placing copies on the Commission's
Electronic Document Information System (EDIS, <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>),
for comment.
Background
On January 28, 2026, Vantage Specialty Chemicals, Inc., Deerfield,
Illinois, filed petitions with the Commission and Commerce, alleging
that an industry in the United States is materially injured or
threatened with material injury by reason of subsidized imports of
fatty acids from Indonesia and Malaysia and LTFV imports of fatty acids
from Indonesia and Malaysia. Accordingly, effective January 28, 2026,
the Commission instituted countervailing duty investigation Nos. 701-
TA-785-786 and antidumping duty investigation Nos. 731-TA-1773-1774
(Preliminary).
Notice of the institution of the Commission's investigations and of
a public conference to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of February 2, 2026 (91 FR 4616).\3\ The
Commission conducted its conference on February 18, 2026. All persons
who requested the opportunity were permitted to participate.
---------------------------------------------------------------------------
\3\ The Commission published a revised schedule on February 17,
2026 (91 FR 7301) to conform with Commerce's new schedule after
Commerce extended the deadline for its initiation determinations
from February 17, 2026 to March 9, 2026 (91 FR 6192, February 11,
2026).
---------------------------------------------------------------------------
The Commission made these determinations pursuant to Sec. Sec.
703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It
completed and filed its determinations in these investigations on April
3, 2026. The views of the Commission are contained in USITC Publication
5723 (April 2026), entitled Fatty Acids from Indonesia and Malaysia:
Investigation Nos. 701-TA-785-786 and 731-TA-1773-1774 (Preliminary).
By order of the Commission.
Issued: April 3, 2026.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2026-06741 Filed 4-7-26; 8:45 am]
BILLING CODE 7020-02-P
</pre></body>
</html>Indexed from Federal Register on April 8, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.